title: Comment on Moore et al. Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes care 2013;36:2981-2987.
authors.affiliation: Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA mark.goodarzi@cshs.org.
authors.forename: Mark O
authors.initials: MO
authors.lastname: Goodarzi
mesh_terms: D003072:Cognition Disorders / Q000453:epidemiology* / Q000209:etiology*; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008687:Metformin / Q000009:adverse effects*
chemical_list: D008687:Metformin